相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer
Shanu Modi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Emerging New Concepts of Degrader Technologies
Yu Ding et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
PROTAC Compounds Targeting α-Synuclein Protein for Treating Neurogenerative Disorders: Alzheimer’s and Parkinson’s Diseases
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2020)
Degradation of Bruton's tyrosine kinase mutants by PROTACs for potential treatment of ibrutinib-resistant non-Hodgkin lymphomas
Yonghui Sun et al.
LEUKEMIA (2019)
Neuroprotective effects of targeting BET proteins for degradation with dBET1 in aged mice subjected to ischemic stroke
Kelly M. DeMars et al.
NEUROCHEMISTRY INTERNATIONAL (2019)
Treatment of Cancer and Alzheimer’s Disease by PROTAC Degradation of EGFR
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2019)
Simple Structural Modifications Converting a Bona fide MDM2 PROTAC Degrader into a Molecular Glue Molecule: A Cautionary Tale in the Design of PROTAC Degraders
Jiuling Yang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo
Longchuan Bai et al.
CANCER CELL (2019)
Allele-selective lowering of mutant HTT protein by HTT-LC3 linker compounds
Zhaoyang Li et al.
NATURE (2019)
Uncoupling of PARP1 trapping and inhibition using selective PARP1 degradation
Shuai Wang et al.
NATURE CHEMICAL BIOLOGY (2019)
Targeted protein degradation: expanding the toolbox
Matthieu Schapira et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion
Robert D. Leone et al.
SCIENCE (2019)
The PROTAC technology in drug development
Yutian Zou et al.
CELL BIOCHEMISTRY AND FUNCTION (2019)
Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase
Blake E. Smith et al.
NATURE COMMUNICATIONS (2019)
Inducing Protein Degradation as a Therapeutic Strategy
Craig M. Crews
JOURNAL OF MEDICINAL CHEMISTRY (2018)
A Click Chemistry Platform for the Rapid Synthesis of Bispecific Molecules for Inducing Protein Degradation
Ryan P. Wurz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Protac-Induced Protein Degradation in Drug Discovery: Breaking the Rules or Just Making New Ones?
Ian Churcher
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Selective degradation of BET proteins with dBET1, a proteolysis-targeting chimera, potently reduces pro-inflammatory responses in lipopolysaccharide-activated microglia
Kelly M. DeMars et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
PROTAC-induced BTK degradation as a novel therapy for mutated BTK C481S induced ibrutinib-resistant B-cell malignancies
Yonghui Sun et al.
CELL RESEARCH (2018)
The Role of Inflammatory Response in Stroke Associated Programmed Cell Death
K. Duris et al.
CURRENT NEUROPHARMACOLOGY (2018)
Discovery of a Keap1-dependent peptide PROTAC to knockdown Tau by ubiquitination-proteasome degradation pathway
Mengchen Lu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Plasticity in binding confers selectivity in ligand-induced protein degradation
Radoslaw P. Nowak et al.
NATURE CHEMICAL BIOLOGY (2018)
Modulation of mitochondrial bioenergetics as a therapeutic strategy in Alzheimer's disease
Isaac G. Onyango
NEURAL REGENERATION RESEARCH (2018)
Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer's Disease
Suzanne M. de la Monte
DRUGS (2017)
Induced protein degradation: an emerging drug discovery paradigm
Ashton C. Lai et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Molecular recognition of ternary complexes: a new dimension in the structure-guided design of chemical degraders
Scott J. Hughes et al.
STRUCTURE-BASED DRUG DESIGN: INSIGHTS FROM ACADEMIA AND INDUSTRY (2017)
BET Bromodomain Proteins Function as Master Transcription Elongation Factors Independent of CDK9 Recruitment
Georg E. Winter et al.
MOLECULAR CELL (2017)
The BET Protein BRD2 Cooperates with CTCF to Enforce Transcriptional and Architectural Boundaries
Sarah C. Hsu et al.
MOLECULAR CELL (2017)
Structural basis of PROTAC cooperative recognition for selective protein degradation
Morgan S. Gadd et al.
NATURE CHEMICAL BIOLOGY (2017)
Functions of bromodomain-containing proteins and their roles in homeostasis and cancer
Takao Fujisawa et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Optogenetics and its application in neural degeneration and regeneration
Josue D. Ordaz et al.
NEURAL REGENERATION RESEARCH (2017)
Small-Molecule Modulation of Protein Homeostasis
George M. Burslem et al.
CHEMICAL REVIEWS (2017)
Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma
Michail S. Lionakis et al.
CANCER CELL (2017)
The Emerging Hallmarks of Cancer Metabolism
Natalya N. Pavlova et al.
CELL METABOLISM (2016)
Mechanisms of resistance and sensitivity to anti-HER2 therapies in HER2+breast cancer
Debora de Melo Gagliato et al.
ONCOTARGET (2016)
Protein Degradation by In-Cell Self-Assembly of Proteolysis Targeting Chimeras
Honorine Lebraud et al.
ACS CENTRAL SCIENCE (2016)
From Krebs to clinic: glutamine metabolism to cancer therapy (vol 16, pg 619, 2016)
Brian J. Altman et al.
NATURE REVIEWS CANCER (2016)
HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of Halo Tag Fusion Proteins
Dennis L. Buckley et al.
ACS CHEMICAL BIOLOGY (2015)
Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4
Michael Zengerle et al.
ACS CHEMICAL BIOLOGY (2015)
Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4
Jing Lu et al.
CHEMISTRY & BIOLOGY (2015)
Catalytic in vivo protein knockdown by small-molecule PROTACs
Daniel P. Bondeson et al.
NATURE CHEMICAL BIOLOGY (2015)
Phthalimide conjugation as a strategy for in vivo target protein degradation
Georg E. Winter et al.
SCIENCE (2015)
Small-Molecule Control of Intracellular Protein Levels through Modulation of the Ubiquitin Proteasome System
Dennis L. Buckley et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Tau Reduction Prevents Aβ-Induced Defects in Axonal Transport
Keith A. Vossel et al.
SCIENCE (2010)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
分享论文
